Company Filing History:
Years Active: 2011-2015
Title: Leon T Van Den Broeke: Innovator in Cancer Treatment
Introduction
Leon T Van Den Broeke is a notable inventor based in Zoutelande, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 3 patents, his work focuses on immunogenic peptides and their applications in combating cancer.
Latest Patents
Among his latest patents, Van Den Broeke has developed immunogenic peptides and methods for treating and preventing cancer. These patents disclose various immunogenic peptides, related fusion proteins, and nucleic acids encoding these peptides or fusion proteins. Additionally, they include conjugates, expression vectors, host cells, and antibodies. His work also encompasses pharmaceutical compositions and vaccines aimed at treating or preventing cancers such as alveolar rhabdomyosarcoma. The methods he has developed stimulate T cells to kill tumor cells and enhance the activity of CD4 and CD8 T cells.
Career Highlights
Leon T Van Den Broeke is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to contribute to groundbreaking research in the field of immunology and cancer treatment.
Collaborations
Throughout his career, Van Den Broeke has collaborated with esteemed colleagues such as Jay A Berzofsky and Lee J Helman. These collaborations have further enriched his research and expanded the impact of his innovations.
Conclusion
Leon T Van Den Broeke stands out as a dedicated inventor whose work in immunogenic peptides is paving the way for new cancer treatments. His contributions to the field are invaluable and continue to inspire advancements in medical science.